Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 1.34 % |
3 Month Return | -2.54 % |
1 Year Return | + 6.27 % |
Market Stats | |
Previous Close | ₹83.10 |
Open | ₹83.10 |
Volume | 21.80K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹179.17Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹179.17 Cr |
P/B Ratio | -1.1 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹179.17 Cr | -0.81% | 0.96 | NA | NA | |
NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Organisation | Krebs Biochemicals & Industries Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Krebs Biochemicals & Industries Ltd
Krebs Biochemicals & Industries Ltd reported standalone net sales of Rs 12.86 crore for September 2024, down 13.67% year-on-year. The company also recorded a net loss of Rs 5.76 crore, a significant increase from the previous year's loss, with EBITDA turning negative at Rs 2.63 crore.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 176.8%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 26.76% of holdings in Sep 2024 quarter
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.49% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 52.3%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.74% of holdings in Sep 2024 quarter
Price Dip
In the last 3 years, KREBSBIO stock has moved down by -46.2%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 72.74% | 0.00 | |
Foreign Institutions | 0.49% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 26.76% | 0.00 | |
Others | 0.01% | 250.00 |
Krebs Biochemicals & Industries Ltd’s net profit fell -61.34% since last year same period to ₹-5.76Cr in the Q2 2024-2025. On a quarterly growth basis, Krebs Biochemicals & Industries Ltd has generated -11.41% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Krebs Biochemicals & Industries Ltd is currently in a Bearish trading position according to technical analysis indicators.
Krebs Biochemicals & Industries Ltd (KREBSBIO) share price today is ₹82.27
Krebs Biochemicals & Industries Ltd is listed on NSE
Krebs Biochemicals & Industries Ltd is listed on BSE
Today’s traded volume of Krebs Biochemicals & Industries Ltd(KREBSBIO) is 21.80K.
Today’s market capitalisation of Krebs Biochemicals & Industries Ltd(KREBSBIO) is ₹179.17Cr.
Krebs Biochemicals & Industries Ltd(KREBSBIO | Price |
---|---|
52 Week High | ₹121.55 |
52 Week Low | ₹60.35 |
Krebs Biochemicals & Industries Ltd(KREBSBIO) share price is ₹82.27. It is down -32.32% from its 52 Week High price of ₹121.55
Krebs Biochemicals & Industries Ltd(KREBSBIO) share price is ₹82.27. It is up 36.32% from its 52 Week Low price of ₹60.35
Krebs Biochemicals & Industries Ltd(KREBSBIO | Returns |
---|---|
1 Day Returns | -0.83% |
1 Month Returns | 1.34% |
3 Month Returns | -2.54% |
1 Year Returns | 6.27% |